Edition:
United Kingdom

Aarti Drugs Ltd (ADRG.NS)

ADRG.NS on National Stock Exchange of India

548.15INR
9:59am GMT
Change (% chg)

Rs-7.60 (-1.37%)
Prev Close
Rs555.75
Open
Rs561.25
Day's High
Rs563.10
Day's Low
Rs545.25
Volume
3,955
Avg. Vol
9,636
52-wk High
Rs662.95
52-wk Low
Rs447.80

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -- March 11 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 1 2,611.00 2,611.00 2,611.00 --
Year Ending Mar-17 1 12,497.00 12,497.00 12,497.00 --
Earnings (per share)
Year Ending Mar-17 1 33.30 33.30 33.30 --

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 3,156.00 3,192.70 36.70 1.16
Quarter Ending Jun-17 2,894.17 2,582.60 311.57 10.77
Quarter Ending Mar-17 2,611.00 2,989.00 378.00 14.48
Quarter Ending Sep-16 3,136.00 3,151.10 15.10 0.48
Quarter Ending Sep-15 2,884.55 2,726.40 158.15 5.48
Earnings (per share)
Quarter Ending Jun-17 9.35 4.77 4.58 48.98
Quarter Ending Sep-15 8.21 6.49 1.72 20.95
Quarter Ending Dec-14 7.94 9.40 1.46 18.32
Quarter Ending Jun-14 7.64 7.12 0.52 6.75
Quarter Ending Mar-14 6.11 9.06 2.95 48.36

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 2,611.00 -- -- -- --
Year Ending Mar-17 12,497.00 -- -- -- --
Earnings (per share)
Year Ending Mar-17 33.30 -- -- -- --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 -- -- -- --
Year Ending Mar-17 -- -- -- --
Earnings
Year Ending Mar-17 -- -- -- --